We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pharma Exec Warns EU Transparency Push Could Delay Drug Applications
Pharma Exec Warns EU Transparency Push Could Delay Drug Applications
October 24, 2013
If EU regulators and pharma cannot agree on how to handle publication of clinical trial data, drugmakers may delay filing applications in Europe to preserve exclusivity, a Pfizer official says.